Home > PS Ratio > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
PS (Price/Sales) Ratio

The Current P/S Ratio of SYNCOM FORMULATIONS (INDIA) is 4.21.

Share Price ₹11.2Mar 28,2024
Market Cap ₹1,050.9 Cr
Sales-TTM₹249.8 CrTTM-Consolidated Results
Price/Sales4.21xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of SYNCOM FORMULATIONS (INDIA)

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of SYNCOM FORMULATIONS (INDIA) is calculated as :

Current Market Cap [ ₹1,050.9 Cr] as on Mar 28,2024

(/) Sales [ ₹249.8 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 4.21x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for SYNCOM FORMULATIONS (INDIA) , the investors are currently willing to pay '4.21 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of SYNCOM FORMULATIONS (INDIA) !

The chart below summarizes the trend in P/S Ratio of SYNCOM FORMULATIONS (INDIA) over the last five years.

Historical PS (Price/Sales) ratio chart of SYNCOM FORMULATIONS (INDIA)


PS Ratio Performance Analysis for SYNCOM FORMULATIONS (INDIA)

- SYNCOM FORMULATIONS (INDIA) 's latest p/e ratio is 4.21x.

- SYNCOM FORMULATIONS (INDIA) 's p/e ratio for fiscal years ending Mar2023 to Mar2015 averaged 2.07x.

- SYNCOM FORMULATIONS (INDIA) 's operated at median p/e ratio of 1.93x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SYNCOM FORMULATIONS (INDIA) 's p/e ratio peaked in Mar2022 at 4.17x.

- SYNCOM FORMULATIONS (INDIA) 's p/e ratio hit its five-year low in Mar2017 of 0.83x.


How does SYNCOM FORMULATIONS (INDIA) 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
SYNCOM FORMULATIONS (INDIA) 249.84.211,050.9
SUN PHARMACEUTICAL INDUSTRIES LTD47,444.68.20388,812.0
CIPLA LTD25,350.24.76120,673.0
DR REDDYS LABORATORIES LTD27,212.53.77102,679.0
ZYDUS LIFESCIENCES LTD19,024.25.32101,152.0
DIVIS LABORATORIES LTD7,492.812.1891,234.9
MANKIND PHARMA LTD9,946.39.2592,029.2
TORRENT PHARMACEUTICALS LTD10,474.08.4188,034.7
LUPIN LTD19,480.13.7873,722.0
AUROBINDO PHARMA LTD27,894.72.2963,835.1
ABBOTT INDIA LTD5,753.49.9557,258.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SYNCOM FORMULATIONS (INDIA) 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.29x
Max industry PS 12.18x
Median industry PS 5.32x
Average industry PS 6.56x



You may also like the below Video Courses